Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04270409
Title Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi

smoldering myeloma


Dexamethasone + Lenalidomide

Dexamethasone + Isatuximab + Lenalidomide

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.